Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

XENE

Xenon Pharmaceuticals (XENE)

Xenon Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XENE
DateTimeSourceHeadlineSymbolCompany
14/11/202408:01GlobeNewswire Inc.Xenon to Present at Upcoming Investor ConferencesNASDAQ:XENEXenon Pharmaceuticals Inc
13/11/202408:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
13/11/202408:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
13/11/202408:01GlobeNewswire Inc.Xenon Reports Q3 2024 Financial Results and Business UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
06/11/202408:01GlobeNewswire Inc.Xenon to Report Q3 2024 Financial Results on November 12, 2024NASDAQ:XENEXenon Pharmaceuticals Inc
03/10/202406:28GlobeNewswire Inc.Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
09/09/202422:30GlobeNewswire Inc.Xenon Showcases Azetukalner Data at 15th European Epilepsy CongressNASDAQ:XENEXenon Pharmaceuticals Inc
12/08/202422:30GlobeNewswire Inc.Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating OfficerNASDAQ:XENEXenon Pharmaceuticals Inc
10/08/202406:57Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:XENEXenon Pharmaceuticals Inc
09/08/202406:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
09/08/202406:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
09/08/202406:01GlobeNewswire Inc.Xenon Reports Q2 2024 Financial Results and Business UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
02/08/202406:01GlobeNewswire Inc.Xenon to Report Q2 2024 Financial Results on August 8, 2024NASDAQ:XENEXenon Pharmaceuticals Inc
13/07/202411:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
13/07/202411:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
13/06/202407:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
06/06/202407:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
06/06/202407:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
06/06/202407:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
06/06/202407:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
06/06/202407:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
06/06/202406:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XENEXenon Pharmaceuticals Inc
06/06/202406:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
06/06/202406:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
28/05/202422:30GlobeNewswire Inc.Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual MeetingNASDAQ:XENEXenon Pharmaceuticals Inc
10/05/202406:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
10/05/202406:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
10/05/202406:01GlobeNewswire Inc.Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202406:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024NASDAQ:XENEXenon Pharmaceuticals Inc
08/05/202406:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:XENE